Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTB + IPACK for ACL Reconstruction Analgesia
NCT05068063Unknown
- Sponsor
- Universidad de Chile
- Start
- Jun 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of bupivacaine in postoperative pain, sponsored by Universidad de Chile. Primary endpoint: Post-operative pain at 2 hours of arrival to Post Anesthesia Care Unit. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05068063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05068063.